Projects per year
Personal profile
Education
- 2006, Ph.D. (Life Science), National Tsing Hua University
- 2000, B.S. (Life Science), National Tsing Hua University
Experience
- 2018- Associate Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery
- 2016-2018 Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery
- 2012-2016 Assistant Professor, The Ph.D. Program for Cancer Biology and Drug Discovery
- 2007-2009 Postdoctoral fellow, National Taiwan University College of Medicine
Awards
- 2012 Young Investigator Award, The Pharmacological Society in Taiwan
Research Interests
- Cancer Biology
- Pharmacology
- Epigenetics
URL
Fingerprint Dive into the research topics where Pei-Ming Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Autophagy
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Securin
Medicine & Life Sciences
Histone Deacetylase Inhibitors
Medicine & Life Sciences
decitabine
Medicine & Life Sciences
Histone Deacetylases
Medicine & Life Sciences
Cadmium
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2019
長鏈非編碼核糖核酸LncHIFCAR/MIR31HG調控的中心網絡在胰臟癌的轉譯研究-探討MIR31HG 調控胰臟癌EMT 及藥物治療反應之作用
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
105大專生計畫獎-楊培銘
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
不同APC基因狀態大腸直腸癌患者藥物治療之抗藥性機轉研究-探討miR-21調控大腸直腸癌細胞TET1/5-hydroxymethylcytosine表現對其化療反應之關聯(3/3)
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
探討miR-21調控大腸直腸癌細胞 TET1/5- hydroxymethylcytosine表現對其化療反應之關聯(2/3)(相對補助)
8/1/16 → 7/31/17
Project: A - Government Institution › f - Other (Funded by Government)
Research Output 2004 2019
In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma
Hsieh, Y. Y., Liu, T. P. & Yang, P. M., Jan 1 2019, In : Pathology Research and Practice.Research output: Contribution to journal › Article
Pituitary Neoplasms
Oncogenes
Renal Cell Carcinoma
Computer Simulation
Neoplasms
1
Citation
(Scopus)
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T. P., Hsieh, Y. Y., Chou, C. J. & Yang, P. M., Nov 1 2018, In : Royal Society Open Science. 5, 11, 181321.Research output: Contribution to journal › Article
Polypharmacology
Drug Repositioning
Databases
Pharmaceutical Preparations
Topoisomerase Inhibitors
4
Citations
(Scopus)
Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer
Cheng, Y. W., Chou, C. J. & Yang, P. M., Mar 1 2018, In : Surgical Oncology. 27, 1, p. 76-81 6 p.Research output: Contribution to journal › Article
Colorectal Neoplasms
5-Methylcytosine
Genes
3' Untranslated Regions
DNA Methylation
Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma
Yang, P-M., Chou, C-J., Tseng, S-H. & Hung, C-F., May 2 2017, In : Oncotarget.Research output: Contribution to journal › Article
Apigenin
Computational Biology
Uterine Cervical Neoplasms
Interferon-gamma
Squamous Cell Carcinoma
1
Citation
(Scopus)
In silico and in vitro identification of inhibitory activities of sorafenib on histone deacetylases in hepatocellular carcinoma cells
Liu, T. P., Hong, Y. H. & Yang, P. M., Oct 17 2017, In : Oncotarget. 8, 49, p. 86168-86180 13 p.Research output: Contribution to journal › Article
Histone Deacetylases
Computer Simulation
Hepatocellular Carcinoma
Polypharmacology
Histone Deacetylase Inhibitors